MedTrace Logo

Study of Avelle™ Negative Pressure Wound Therapy (NPWT) System

NCT05805046 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-04-30

No results posted yet for this study

Summary

The main questions the study aims to answer are:

* How much do wounds improve when using the Avelle™ Negative Pressure Wound Therapy System for a maximum of 14 days?
* How safe is the Avelle™ Negative Pressure Wound Therapy System?

Conditions

  • Surgical Wound, Recent
  • Surgical Wound Leak
  • Dehiscence Wound
  • Trauma-related Wound

Interventions

DEVICE

Negative Pressure Wound Therapy System

The study device combines a sterile dressing comprising gelling fibre technology to absorb wound exudate with negative pressure applied to the wound via a vacuum pump.

Sponsors & Collaborators

  • ConvaTec Inc.

    lead INDUSTRY

Principal Investigators

  • Cristin Taylor · AWC Senior Director, Convatec

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-30
Primary Completion
2023-10-30
Completion
2023-10-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05805046 on ClinicalTrials.gov